• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

手术患者的抗凝血酶、前激肽释放酶和纤连蛋白水平。

Antithrombin, prekallikrein, and fibronectin levels in surgical patients.

作者信息

Wilson R F, Mammen E F, Robson M C, Heggers J P, Soullier G, DePoli P A

出版信息

Arch Surg. 1986 Jun;121(6):635-40. doi: 10.1001/archsurg.1986.01400060029002.

DOI:10.1001/archsurg.1986.01400060029002
PMID:3486649
Abstract

Antithrombin (AT), prekallikrein (PK), and fibronectin (FN) levels were measured in the plasma of 290 patients. The mean (+/- SD) lowest AT level measured in 287 patients was 70% +/- 18% (normal, 75% to 120% of control). The mean lowest AT level in 81 septic patients (49% +/- 17%) was significantly lower than in the 206 patients without sepsis (78% +/- 22%). The mean AT level in 60 patients who died (42% +/- 22%) was significantly lower than in 227 patients who lived (78% +/- 19%). The mean lowest PK level measured in 71 patients was 42% +/- 17% (normal, 80% to 120%). The mean PK level in 32 septic patients (26% +/- 12%) was significantly lower than in 39 patients who were not septic (54% +/- 19%). The mean lowest FN level measured in 45 patients was 193 +/- 86 micrograms/mL (normal, 160 to 240 micrograms/mL). The mean FN level in 15 septic patients (128 +/- 72 micrograms/mL) was significantly lower than in the 30 nonseptic patients (266 +/- 84 micrograms/mL). Following AT, PK, and FN levels in critically ill surgical patients may allow earlier diagnosis and more effective treatment of sepsis.

摘要

在290例患者的血浆中检测了抗凝血酶(AT)、前激肽释放酶(PK)和纤连蛋白(FN)水平。287例患者测得的平均(±标准差)最低AT水平为70%±18%(正常为对照值的75%至120%)。81例脓毒症患者的平均最低AT水平(49%±17%)显著低于206例无脓毒症患者(78%±22%)。60例死亡患者的平均AT水平(42%±22%)显著低于227例存活患者(78%±19%)。71例患者测得的平均最低PK水平为42%±17%(正常为80%至120%)。32例脓毒症患者的平均PK水平(26%±12%)显著低于39例非脓毒症患者(54%±19%)。45例患者测得的平均最低FN水平为193±86微克/毫升(正常为160至240微克/毫升)。15例脓毒症患者的平均FN水平(128±72微克/毫升)显著低于30例非脓毒症患者(266±84微克/毫升)。监测重症外科患者的AT、PK和FN水平可能有助于脓毒症的早期诊断和更有效的治疗。

相似文献

1
Antithrombin, prekallikrein, and fibronectin levels in surgical patients.手术患者的抗凝血酶、前激肽释放酶和纤连蛋白水平。
Arch Surg. 1986 Jun;121(6):635-40. doi: 10.1001/archsurg.1986.01400060029002.
2
Sepsis and antithrombin III, prekallikrein, and fibronectin levels in surgical patients.
Am Surg. 1989 Jul;55(7):450-6.
3
Influence of plasma protease activation on electroimmunoassay and nephelometry of plasma fibronectin in sepsis.血浆蛋白酶激活对脓毒症患者血浆纤连蛋白免疫电泳和散射比浊法检测的影响
Thromb Res. 1989 Dec 15;56(6):731-7. doi: 10.1016/0049-3848(89)90290-9.
4
[Hemostasis in burn patients and treatment with heparin. Relation to prognosis and infection. Pattern of blood levels of prekallikrein, alpha-2-macroglobulin, antithrombin III, plasminogen and alpha-2-antiplasmin].[烧伤患者的止血与肝素治疗。与预后和感染的关系。前激肽释放酶、α-2-巨球蛋白、抗凝血酶III、纤溶酶原和α-2-抗纤溶酶的血液水平模式]
Nouv Rev Fr Hematol (1978). 1982;24(6):375-81.
5
Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).疑似弥散性血管内凝血(DIC)的危重症患者的血浆前激肽释放酶、因子 XII、抗凝血酶 III、C1(-)抑制剂和α2-巨球蛋白
Am J Clin Pathol. 1984 Oct;82(4):396-404. doi: 10.1093/ajcp/82.4.396.
6
Evaluation of potential early markers of chorioamnionitis associated with preterm premature ruptured membranes.
Am J Perinatol. 1990 Jan;7(1):33-5. doi: 10.1055/s-2007-999441.
7
Uncontrolled plasma proteolysis: a major threat to the septicemic patient.
Resuscitation. 1986 Sep;14(1-2):33-42. doi: 10.1016/0300-9572(86)90005-5.
8
[Burns and heparin therapy: prekallikrein and other hemostatic parameters].
Agressologie. 1983 Nov;24(11):539-40.
9
Determination of prekallikrein using an amidolytic assay in plasma samples of critically ill patients.在危重症患者血浆样本中使用酰胺水解测定法测定前激肽释放酶。
Acta Chir Scand Suppl. 1982;509:43-7.
10
The overwhelming inflammatory response and the role of endotoxin in early sepsis.早期脓毒症中压倒性的炎症反应及内毒素的作用。
Prog Clin Biol Res. 1989;308:371-6.

引用本文的文献

1
Antithrombin Therapy: Current State and Future Outlook.抗凝血酶治疗:现状与未来展望。
Clin Appl Thromb Hemost. 2023 Jan-Dec;29:10760296231205279. doi: 10.1177/10760296231205279.
2
Prospective randomized study of the benefits of preoperative corticosteroid administration on hepatic ischemia-reperfusion injury and cytokine response in patients undergoing hepatic resection.前瞻性随机研究术前皮质类固醇给药对肝切除患者肝缺血再灌注损伤和细胞因子反应的益处。
HPB (Oxford). 2007;9(3):183-9. doi: 10.1080/13651820701216984.
3
Antithrombin supplementation for anticoagulation during continuous hemofiltration in critically ill patients with septic shock: a case-control study.
抗凝血酶补充剂用于脓毒性休克重症患者持续血液滤过期间的抗凝治疗:一项病例对照研究。
Crit Care. 2006;10(2):R45. doi: 10.1186/cc4853.
4
Influence of modest endotoxemia on postoperative antithrombin deficiency and circulating secretory immunoglobulin a levels.轻度内毒素血症对术后抗凝血酶缺乏及循环分泌型免疫球蛋白A水平的影响。
Ann Surg. 2003 Aug;238(2):258-63. doi: 10.1097/01.sla.0000082711.77096.71.
5
Antithrombin III (ATIII) replacement therapy in patients with sepsis and/or postsurgical complications: a controlled double-blind, randomized, multicenter study.抗凝血酶III(ATIII)替代疗法用于脓毒症和/或术后并发症患者:一项对照双盲、随机、多中心研究。
Intensive Care Med. 1998 Apr;24(4):336-42. doi: 10.1007/s001340050576.
6
Coagulation disorders in septic shock.脓毒性休克中的凝血障碍。
Intensive Care Med. 1993;19 Suppl 1:S8-15. doi: 10.1007/BF01738944.
7
Use of antithrombin III in critical patients.抗凝血酶III在重症患者中的应用。
Intensive Care Med. 1994 Nov;20(8):577-80. doi: 10.1007/BF01705725.
8
[Follow-up of infected patients in an intensive care unit using the "infection score," endotoxin and AT III determination].
Langenbecks Arch Chir. 1988;373(3):166-72. doi: 10.1007/BF01274229.
9
The adult respiratory distress syndrome--20 years on.成人呼吸窘迫综合征——20年回顾
Thorax. 1987 Sep;42(9):641-5. doi: 10.1136/thx.42.9.641.